SUBSCRIBE
SUBSCRIBE

Curis, Inc.

NEWS
The Day In Review: Biotech Succumbs To Market Pressure
October 19, 2005
 · 
1 min read
Deals
Top 2003 Stories From The BioSpace NewsBeat
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Deals
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - January 5, 2024
January 5, 2024
 · 
2 min read
Genetown
Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study
December 12, 2023
 · 
7 min read
Genetown
Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference
December 11, 2023
 · 
7 min read
Genetown
Curis Announces Three Presentations at ASH
December 6, 2023
 · 
7 min read
Business
Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma
December 5, 2023
 · 
6 min read
Business
Curis Provides Third Quarter 2023 Business Update
November 2, 2023
 · 
11 min read
Business
Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023
October 26, 2023
 · 
1 min read
Genetown
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - October 06, 2023
October 6, 2023
 · 
2 min read
Genetown
Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer
September 12, 2023
 · 
5 min read
Genetown
Curis to Present at Upcoming Healthcare Conferences in September
September 6, 2023
 · 
2 min read
Load More